UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$155M |
| 2 |
Wells Fargo
WFC
|
+$134M |
| 3 |
Biogen
BIIB
|
+$121M |
| 4 |
Alibaba
BABA
|
+$108M |
| 5 |
Delta Air Lines
DAL
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$255M |
| 2 |
Chevron
CVX
|
+$220M |
| 3 |
Bank of Montreal
BMO
|
+$192M |
| 4 |
Canadian Imperial Bank of Commerce
CM
|
+$191M |
| 5 |
Enbridge
ENB
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.93% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVA
1576
DELISTED
Covanta Holding Corporation
CVA
| $1.53M | ﹤0.01% |
94,296
-12,612
| -12% | -$216K |
|
|
AVYA
1577
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $1.53M | ﹤0.01% |
69,150
+5,274
| +8% | +$113K |
|
1578
HNI Corp
HNI
$3.59B
| $1.53M | ﹤0.01% |
34,592
+1,123
| +3% | +$47.4K |
|
1579
DNOW Inc
DNOW
$2.99B
| $1.53M | ﹤0.01% |
92,450
-10,998
| -11% | -$174K |
|
|
SRCI
1580
DELISTED
SRC Energy Inc
SRCI
| $1.53M | ﹤0.01% |
171,671
-616
| -0.4% | -$6.14K |
|
1581
Pegasystems
PEGA
$5.38B
| $1.53M | ﹤0.01% |
48,756
+6,230
| +15% | +$188K |
|
1582
J&J Snack Foods
JJSF
$1.71B
| $1.52M | ﹤0.01% |
10,048
+542
| +6% | +$80.6K |
|
1583
Innospec
IOSP
$2.28B
| $1.51M | ﹤0.01% |
19,677
| – | – |
|
1584
United Natural Foods
UNFI
$2.85B
| $1.51M | ﹤0.01% |
50,330
+430
| +0.9% | +$15.6K |
|
1585
Lithia Motors
LAD
$8.26B
| $1.5M | ﹤0.01% |
18,418
-1,303
| -7% | -$115K |
|
1586
Advanced Energy
AEIS
$13B
| $1.5M | ﹤0.01% |
29,075
+2,326
| +9% | +$135K |
|
|
GOLD
1587
DELISTED
Randgold Resources Ltd
GOLD
| $1.49M | ﹤0.01% |
21,118
+2,998
| +17% | +$206K |
|
1588
Repligen
RGEN
$9.25B
| $1.49M | ﹤0.01% |
26,855
+2,678
| +11% | +$138K |
|
1589
Liberty Latin America Class C
LILAK
$1.64B
| $1.48M | ﹤0.01% |
+83,991
| New | +$1.42M |
|
1590
Prestige Consumer Healthcare
PBH
$2.6B
| $1.48M | ﹤0.01% |
39,145
| – | – |
|
1591
G-III Apparel Group
GIII
$1.5B
| $1.48M | ﹤0.01% |
30,758
+701
| +2% | +$31.9K |
|
1592
Horace Mann Educators
HMN
$2.11B
| $1.48M | ﹤0.01% |
32,983
| – | – |
|
1593
Insight Enterprises
NSIT
$4.38B
| $1.48M | ﹤0.01% |
27,292
| – | – |
|
1594
CONMED
CNMD
$1.47B
| $1.47M | ﹤0.01% |
18,604
+33
| +0.2% | +$2.55K |
|
|
ARNA
1595
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.47M | ﹤0.01% |
32,021
| – | – |
|
|
CCMP
1596
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $1.47M | ﹤0.01% |
14,276
-85
| -0.6% | -$9.59K |
|
1597
NETSCOUT
NTCT
$2.79B
| $1.47M | ﹤0.01% |
58,243
| – | – |
|
|
POLY
1598
DELISTED
Plantronics, Inc.
POLY
| $1.47M | ﹤0.01% |
24,345
+439
| +2% | +$30K |
|
1599
Kaiser Aluminum
KALU
$3.02B
| $1.47M | ﹤0.01% |
13,455
+400
| +3% | +$43.4K |
|
1600
Medifast
MED
$141M
| $1.46M | ﹤0.01% |
6,593
-200
| -3% | -$40.5K |
|
Similar funds
UBS AM's Q3 2018 Portfolio in Review
As of Q3 2018, UBS AM held 2,869 positions worth $135B, up 3.1% from $130B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS AM's Q3 2018 filing shows 86 new, 1,174 increased, 804 reduced and 106 closed positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M. The largest sale was Scotiabank, an estimated $255M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q3 2018 buy was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M.
- UBS AM added most to Allergan plc in Q3 2018, an estimated $155M increase.
- UBS AM's biggest Q3 2018 reduction was Scotiabank, cutting an estimated $255M.
- UBS AM fully exited BCE in Q3 2018, selling an estimated $35M.
- UBS AM's ten largest holdings make up 18% of its $135B portfolio in Q3 2018.
- UBS AM opened 86 new positions and closed 106 in Q3 2018.
- UBS AM's portfolio value rose 3.1% quarter-over-quarter to $135B.
Based on UBS AM's 13F filing for Q3 2018, filed 14 Nov 2018.